Figure 1. A representative MRD follow-up... | American Society of Hematology

Figure 1.

$Figure 1. A representative MRD follow-up during CR1, relapse and following by CR2 obtained after fractionated GO + cytarabine (Ara-C)$

A representative MRD follow-up during CR1, relapse and following by CR2 obtained after fractionated GO + cytarabine (Ara-C)